Daily Derm Times: April 7, 2025

Author(s):

Emma Andrus, Editor

Key Takeaways

A novel injection technique effectively prevents sunken cheeks in masseter hypertrophy treatment, with high patient satisfaction observed four weeks post-injection.
Tofacitinib demonstrates efficacy in reducing itch and skin infiltration in prurigo nodularis, though its effects may diminish over time.
The large-spot, variable-pulsed KTP laser is a safe and effective alternative to PDL for treating port-wine birthmarks over a three-year period.
Current JAK inhibitors are approved only for patients aged 12 and older, limiting treatment options for younger pediatric AD patients.
Dupilumab significantly improves Dermatology Life Quality Index (DLQI) and Investigator's Global Assessment (IGA) scores in patients with moderate to severe atopic dermatitis.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Novel Injection Technique Prevents Sunken Cheek in Masseter Hypertrophy Treatment

The method was safe and effective with high patient satisfaction rates 4 weeks post-injection.

Shaping the Future of Dermatology With Insights From AAD 2025 and Beyond

Explore key takeaways from AAD 2025, rosacea insights, psoriasis updates, and expert interviews in the latest issue of Dermatology Times.

Study Reports Efficacy of Tofacinitib in Itch, Skin Infiltration Reduction for Prurigo Nodularis

Tofacitinib showed promise for easing itch and skin symptoms in prurigo nodularis, though effects may lessen over time.

Balancing Safety and Progress in Pediatric AD

Current JAK inhibitors are approved only for those 12 and older, leaving younger patients without access.

Large-Spot, Variable-Pulsed KTP Laser Demonstrates Safety and Efficacy in Port-Wine Birthmarks

Long-pulsed KTP laser showed promise as a safe, effective alternative to PDL for treating port-wine birthmarks over 3 years.

Bridging Medicine and Machine Learning

The guide prepares students to critically engage with AI tools and understand their real-world implications.

Allergic Contact Dermatitis Remains Prevalent, Negatively Impacts Quality of Life

Researchers conducted a comprehensive review of ACD, detailing the condition’s epidemiology, pathophysiology, clinical manifestations, diagnostic approaches, and therapeutic options.

Dupilumab Improves DLQI and IGA Scores in Hand and Facial Eczema in Patients With Moderate to Severe AD

Patients reported the face, neck, and inner arms as the most affected body regions before treatment.

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe Now!